Epidermal growth factor receptor (EGFR) gene mutation testing prior to tyrosine kinase inhibitors (TKI) treatment – prospective data from the Czech TULUNG registry

J. Skricková (Brno, Czech Republic), P. Májková (Brno, Czech Republic), M. Barinová (Brno, Czech Republic), M. Bratová (Brno, Czech Republic), M. Pešek (Plzen, Czech Republic), M. Svaton (Plzen, Czech Republic), V. Kolek (Olomouc, Czech Republic), O. Fišer (Olomouc, Czech Republic), L. Koubková (Praha, Czech Republic), A. Benejová (Brno, Czech Republic), O. Venclícek (Brno, Czech Republic), M. Cernovská (Praha, Czech Republic), L. Havel (Praha, Czech Republic), M. Hrnciarik (Hradec Králové, Czech Republic), J. Roubec (Ostrava, Czech Republic), Z. Milada (Praha, Czech Republic), P. Opálka (Praha, Czech Republic), J. Krejcí (Praha, Czech Republic), D. Krejcí (Praha, Czech Republic), H. Coupková (Brno, Czech Republic), Z. Merta (Brno, Czech Republic)

Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology
Session: Real-world data and registries of thoracic oncology
Session type: E-poster session
Number: 1686
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Skricková (Brno, Czech Republic), P. Májková (Brno, Czech Republic), M. Barinová (Brno, Czech Republic), M. Bratová (Brno, Czech Republic), M. Pešek (Plzen, Czech Republic), M. Svaton (Plzen, Czech Republic), V. Kolek (Olomouc, Czech Republic), O. Fišer (Olomouc, Czech Republic), L. Koubková (Praha, Czech Republic), A. Benejová (Brno, Czech Republic), O. Venclícek (Brno, Czech Republic), M. Cernovská (Praha, Czech Republic), L. Havel (Praha, Czech Republic), M. Hrnciarik (Hradec Králové, Czech Republic), J. Roubec (Ostrava, Czech Republic), Z. Milada (Praha, Czech Republic), P. Opálka (Praha, Czech Republic), J. Krejcí (Praha, Czech Republic), D. Krejcí (Praha, Czech Republic), H. Coupková (Brno, Czech Republic), Z. Merta (Brno, Czech Republic). Epidermal growth factor receptor (EGFR) gene mutation testing prior to tyrosine kinase inhibitors (TKI) treatment – prospective data from the Czech TULUNG registry. 1686

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: